Light Mode
$0.0007 ↑ +0.0002 (+40.00%) Trading Up from the previous close of $0.0005, and at the day’s high of $0.0007
+0.00 (+40.00%) / 6M
Momentum, market sentiment, and recent alerts
PXMD reads n/a: the 12-month move is +600.0%.
No alerts for PXMD in the last day.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
PaxMedica, Inc. is a clinical stage biopharmaceutical company. It engages in the business of developing drug candidates for the treatment of autism spectrum disorder, Fragile X syndrome tremor-ataxia, and Human African Trypanosomiasis. The company was founded by Michael L. Derby on April 5, 2018 and is headquartered in Tarrytown, NY.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.